Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
69.96 USD | -0.01% |
|
+4.90% | -13.64% |
Jul. 11 | Morgan Stanley Adjusts Price Target on Gilead Sciences to $74 From $78 | MT |
Jul. 09 | RBC Cuts Price Target on Gilead Sciences to $71 From $74, Keeps Sector Perform Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.64% | 87.17B | |
+62.66% | 841B | |
+40.42% | 625B | |
-4.37% | 360B | |
+17.16% | 327B | |
+9.87% | 300B | |
+15.66% | 242B | |
+17.90% | 227B | |
+14.86% | 174B | |
+0.45% | 162B |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- Transcript : Gilead Sciences, Inc. Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 11